BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35580469)

  • 1. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.
    Walker LAS; Marino D; Berard JA; Feinstein A; Morrow SA; Cousineau D
    Can J Neurol Sci; 2017 Sep; 44(5):547-555. PubMed ID: 28683843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
    Maubeuge N; Deloire MS; Brochet B; Charré-Morin J; Saubusse A; Ruet A
    Mult Scler; 2022 Jun; 28(7):1112-1120. PubMed ID: 34766866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimal neuropsychological assessment of MS patients (MACFIMS): normative data of the Italian population.
    Grossi P; Portaccio E; Bellomi F; Bianchi V; Cilia S; Falautano M; Goretti B; Pietrolongo E; Viterbo RG; Messmer Uccelli M
    Neurol Sci; 2020 Jun; 41(6):1489-1496. PubMed ID: 31953702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
    Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
    Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Parmenter BA; Testa SM; Schretlen DJ; Weinstock-Guttman B; Benedict RH
    J Int Neuropsychol Soc; 2010 Jan; 16(1):6-16. PubMed ID: 19796441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Subtle Cognitive Impairment in Multiple Sclerosis with the Montreal Cognitive Assessment.
    Charest K; Tremblay A; Langlois R; Roger É; Duquette P; Rouleau I
    Can J Neurol Sci; 2020 Sep; 47(5):620-626. PubMed ID: 32450922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample.
    Marrie RA; Whitehouse CE; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff LA; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD
    Front Neurol; 2020; 11():621010. PubMed ID: 33519702
    [No Abstract]   [Full Text] [Related]  

  • 11. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
    Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Gromisch ES; Portnoy JG; Foley FW
    J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis.
    Matías-Guiu JA; Sánchez-Benavides G; Rivera-Àvila N; Cortés-Martínez A; Delgado-Alonso C; Delgado-Álvarez A; Montero P; Pytel V; Matías-Guiu J; Peña-Casanova J
    Mult Scler Relat Disord; 2020 Jul; 42():102070. PubMed ID: 32330845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao's brief repeatable battery in the Portuguese population.
    Sousa C; Rigueiro-Neves M; Passos AM; Ferreira A; Sá MJ;
    BMC Neurol; 2021 Apr; 21(1):170. PubMed ID: 33882847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Benedict RH; Cookfair D; Gavett R; Gunther M; Munschauer F; Garg N; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2006 Jul; 12(4):549-58. PubMed ID: 16981607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of conventional cognitive tests in multiple sclerosis: Application of item response theory.
    Raimo S; Giorgini R; Gaita M; Costanzo A; Spitaleri D; Palermo L; Liuzza MT; Santangelo G
    Mult Scler Relat Disord; 2023 Jan; 69():104440. PubMed ID: 36495845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising cognitive screener in multiple sclerosis: The NIH toolbox cognition battery concords with gold standard neuropsychological measures.
    Manglani HR; Fisher ME; Duraney EJ; Nicholas JA; Prakash RS
    Mult Scler; 2022 Oct; 28(11):1762-1772. PubMed ID: 35531593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.